Heart Health Problems Start Sooner in Childhood Cancer Survivors

Compared to siblings with no history of cancer treatment, childhood cancer survivors may have undiagnosed heart problems while still young.

Survivorship in the U.S. is a means of treating survivors of cancer, and it tends to look at the long-term picture in which many survivors are at risk for a host of health problems related to their cancer treatment.

Examining heart health

New (unpublished) research presented at the annual meeting of the American Heart Association suggests that some of those health problems considered long-term may actually be affecting patients when they're still young.

In a news release, Donald Dengel, a kinesiology professor at the University of Minnesota in Minneapolis, said:

Research has shown childhood cancer survivors face heart and other health problems decades after treatment. But researchers had not, until now, looked at the heart health effects of childhood cancer treatment while survivors are still children.

Dengel and colleagues looked at artery stiffness, thickness and function in more than 300 patients between the ages of 9 and 18 who had reached the five-year mark since their diagnosis with a childhood cancer. They were compared to a control group of more than 200 siblings with no cancer history.

Survivors at higher risk

The researchers found that survivors were more likely than their siblings to experience a decline in arterial function (one that could indicate premature heart disease) and a decrease in arterial health.

Researchers recommend lifestyle changes for survivors that take into consideration this risk, and further, that those in health care who work in survivorship make cardiovascular risk factors a priority for patients immediately after the patient has completed therapy.

Source: Newsday

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap